IFPMA’s 10 principles on counterfeit medicines
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) published its “Ten Principles on Counterfeit Medicines” to draw public attention to the issue.
The principles define counterfeit medicines, describe the threats they pose, suggest ways to prevent counterfeit drugs from reaching patients, and urge support for the World Health Organization (WHO) and its International Medical Products Anti-Counterfeiting Taskforce (IMPACT).
“Counterfeit medicines are a crime, and our industry is serious about tackling this problem head on,” said Haruo Naito, president of IFPMA and president and CEO of Eisai (Tokyo), in an IFPMA press release. Counterfeiters pose a threat to global public health by attempting to present their products as legitimate medicines, he added. “We stand ready to be an active partner in WHO-led efforts, including IMPACT.”
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.
Learn more
Related news and resources
How we are contributing to global pharmaceutical standards
The evolving global pharmaceutical regulatory environment and the increasing interest of new countries in joining the ICH highlights the importance of maintaining consistent interpretation and implementation of ICH guidelines among industry and regulatory authorities worldwide. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), along with other ICH Members and Observers, has an important role...
Read more
The socio-economic value of adult immunisation programmes
Download this OHE report, commissioned by IFPMA, to learn more about the socio-economic value of adult vaccination programems on individual lives and societies at large.
Read more
Open letter from the biopharmaceutical industry to G20 Ministers in support of the advancement of the G20 Health Agenda
On 9 April 2024, IFPMA, Interfarma, and FIFARMA submitted an open letter to G20 Ministers in support of the advancement of the G20 Health Agenda. The letter is available for download in English, Portuguese, and Spanish.
Read more